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Introduction. Since the Stoneburner Lecturer for 
this year, Dr. Thomas Langfitt, is Professor and 
Chairman at the hospital of the University of Penn-
sylvania, it would only be proper to recall at least one 
of the important lessons taught by Dr. Francis Grant, 
Dr. Langfitt's predecessor at the University of Penn-
sylvania. One of Dr. Grant's most remembered dic-
tums was that when a benign brain tumor is en-
countered, the best surgical team the clinic can 
assemble should be put to work on it (I). This is a 
valuable concept in the treatment of benign brain 
tumors. It is of paramount importance to protect the 
brain, to preserve neurological function, to restore 
neurological function which has been lost, and to 
remove the tumor completely if possible. Ample 
statistics reveal a 20% recurrence rate in operated 
benign central nervous system tumors, a rate largely 
related to incomplete removal at the first operation 
(2). 
What are the recent advances which will ensure a 
better fate for the brain tumor patient? First is the 
diagnosis of the degree, if any, of increased in-
tracranial pressure (ICP) before surgery; second is the 
meticulous management of anesthesia at surgery; and 
third is the use of the operating microscope with the 
associated microneurosurgical instrumentation to 
provide magnification surgery. 
Intracranial Pressure. The recognition of in-
creased intracranial pressure is important not only in 
benign brain tumors but all brain tumors which 
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manifest increased intracranial pressure by headache, 
altered states of consciousness, and the finding of 
papilledema. All brain tumor patients treated at 
MCY have ICP monitoring for three-to-five days 
before surgery, during surgery, and for at least three 
days following surgery with a subarachnoid screw (3). 
Figure I is a recording of intracranial pressure 
demonstrating increased intracranial pressure as the 
patient is being monitored before and during steroid 
treatment prior to surgery. 
If the baseline ICP is elevated above 40 mm Hg 
(normal less than 11 mm Hg), there will usually be 
plateau waves-a transient marked increase in ICP 
up to 60 Hg. With the rise in ICP or at the time of a 
plateau wave, there may be a decrease in the level of 
consciousness, hypoventilation, and an increase in Paco . 
The patient may then be aroused by severe headache;, 
or by an examiner, and may then hyperventilate, 
lowering the Paco , relieving the headache, and re-
turning intracrani~I pressure to the baseline. 
We have found, upon establishing the baseline 
ICP, that there is usually no rapid reduction of ICP in 
the first 24 hours of steroid therapy even though 
clinical improvement is seen during the same period. 
We have often observed a decrease in the number of 
plateau or Lundberg waves occurring in the first 
24-36 hours of steroid treatment. Early clinical im-
provement in the patient's condition, not associated 
with a lowering of mean ICP, may reflect a direct 
effect of steroids on the brain or improvement in 
cerebral blood flow as brain edema is reduced. 
Because ICP is usually reduced only after at least 
24-36 hours of steroids, all of our patients are 
prepar,ed for brain tumor surgery with three-to-five 
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days of steroids. During this long period of time, in 
which steroids may be necessary to reduce ICP, effect 
membrane stabilization and capillary integrity, they 
also may have a beneficial effect on other subcellular 
organelles such as lysosomes, which appear better 
preserved when the patient has been well prepared 
with steroids. Without steroids, under stress of 
trauma, breakdown of lysosomes results in formation 
of lipofuscin bodies and the release not only of acid 
phosphatases, but of other hydrolytic enzymes as well 
(4). Experimental evidence also reveals a decrease in 
the severity of the traumatized brain when treated 
with steroids (5); thus, we use ICP monitoring and 
long-term steroid administration prior to surgery to 
reduce ICP and to protect the brain from any trauma 
that may occur during surgery. 
Anesthesia. The next important aspect of the 
management of patients with benign brain tumors is 
induction of anesthesia. This is a most critical time 
for the patient. Even preoperative sedation can cause 
hypoventilation, blood gas changes, and alterations 
in intracranial pressure between the time the patient 
leaves the floor and the time he arrives in the 
operating room. All brain tumor patients undergoing 
surgery have intracranial pressure subarachnoid 
monitoring not only preoperatively but during the 
induction of anesthesia as well. Likewise, an arterial 
line from the patient's radial artery is connected to a 
4 channel Grass recorder, and end-expiratory C02 is 
measured on a capnograph. By this technique we 
have been able to confirm that there are many times 
during the induction of anesthesia when a change in 
ICP may occur (6). A rise in ICP may be hazardous 
for the patient if increased intracranial pressure is 
present at the induction of anesthesia. It is best to 
have knowledge of the intracranial pressure prior to 
the induction of anesthesia as hyperventilation or in-
travenous mannitol may be needed to reduce in-
tracranial pressure. For instance, while halothane is 
not a dangerous anesthetic, increasing its concentra-
tion quickly increases intracranial pressure. Figure 2 
shows the reduction of ICP when intravenous pen-
tothal is administered. This is in agreement with 
Shapiro's recent report showing that thiopental 
sodium, or pentobarbital, will reduce intracranial 
pressure (7). Ethane is an agent useful in lowering in-
tracranial pressure unless increased to a concentra-
tion of 4% or more. lntracranial pressure monitoring 
reveals a balanced barbiturate anesthetic to be a 
valuable anesthetic technique in brain tumor surgery. 




Fig. 1-lntracranial pressure recording in mm Hg during 5 days of 
steroid (Decadron® 4 mg l m q6h) treatment. On day I and 2 
baseline ICP runs between 30-40 mm Hg with plateau waves up to 
60 mm Hg. Plateau waves disappear on day 3 but baseline ICP is 
only in normal range on the fifth day of treatment. 
increase in intracranial pressure associated with a 
small change in arterial blood pressure (Fig. 2). A 
short period of straining on the endotracheal tube 
will likewise produce a rise in ICP, and prolonged 
straining or "bucking" must not be allowed. 
After the induction of anesthesia, the surgeon 
must carefully position the patient's head for his sur-
gical advantage without turning the head so severely 
that a major blood vessel to or from the head is 
occluded; this is often overlooked in preparing the 
patient for surgery. Care must be taken not to 
obstruct venous drainage from the head as this will 
certainly increase ICP. 
INTRACRANIAL PRESSURE AND BLOOD PRESSURE 
CHANGES AT ANESTHESIA INDUCTION 
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Fig. 2-(Top Tracing) Pentothal lowering ICP within I minute of 
administration ; 50 mg pentothal produced a slight decrease in ICP 
while 350 mg produced a marked decrease in ICP. (Bottom Trac-
ing) Rise in ICP to almost 60 mm Hg during intubation. 
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Following the induction, both the surgeon and 
the anesthesiologist must also focus on ventilation of 
the patient. Figure 3 is the ICP recording of an opera-
tion on the posterior fossa where spontaneous 
respiration is generally used since it is a safeguard 
against undue trauma or traction of the br;iinstem. 
Spontaneous respiration produced a prompt rise in 
intracranial pressure and the patient was then placed 
on a respirator to control ventilation and reduce ICP. 
In order to operate on an ;idult patient, intracranial 
pressure is maintained in a safe range with ventilation 
controlled at the rate of 12 respirations/ min and a 
tidal volume of 900 cc with each respiration . Unfor-
tunately, when the surgeon is operating he may, 
nevertheless, reach a point where he is about to open 
the dura only to find it very tight. If the surgeon 
demands that the anestheti st hyperventilate the 
patient, an over reaction by the anesthetist of rapid 
hand ventilation may result in exchange of a small 
tidal volume too rapidly for sufficient venous return 
and intracranial pressure may not be lowered but 
may actually be increased . The induction of 
anesthesia must be attended by the neurosurgeon as 
well as the anesthetist. This is one of the most impor-
tant aspects of the operation, errors in management 
of the anesthetic resulting in intracranial pressure 
changes could lead to a tragic result from the operation. 
Magnification Surgery. One of the reasons for 
emphasizing control of intracranial pressure and the 
induction of anesthesia is that it is important, in the 
technique of operating on a brain tumor using an 
operating microscope, to have as much exposure as 
possible often beneath the brain or deep within the 
SPONTANEOUS AND ASSISTED 
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Fig. 3-lntracranial pressure recording during posterior fossa sur-
gery demonstrating repeated elevation of ICP whenever the patient 
is allowed to breath spontaneously. This elevation of ICP is cor-
rected by assisting respiration (Top Tracing). 
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Fig. 4-Ceiling-mounted operating microscope in the 
neurosurgical operating room at the Medical College of Virginia. 
Focusing is accomplished by foot control pedal not shown in 
figure. 
brain without retracting the brain . Careful attention 
to the small metabolic parameters discussed above 
;ifford a much better opportunity to operate on the 
brain under relaxed conditions. Brain retractors 
should be used to protect the brain, not to retract the 
brain, and the tumor must be removed from the 
brain, not the brain from the tumor. The operating 
microscope has changed our approach not only to in-
tracranial vascular surgery, where it is absolutely 
necessary, but also to benign brain tumor surgery as 
well. Presently the only type of tumors not requiring 
use of a microscope are malignant gliomas of the 
cerebral hemispheres. 
At MCV a ceiling-mounted microscope allows 
the surgeon and one assistant or resident to see and 
become involved in the operation (Fig. 4). The best 
place to install a ceiling-mounted microscope is in the 
center of the operating room. Many surgeons prefer 
the floor-mounted movable microscope, finding it 
easier to move the microscope to the patient than to 
move the patient to the fixed microscope. The 
limitations of the microscope earlier in our ex-
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perience included the fact that it made resident 
teaching difficult and did not allow the scrub nurse or 
the anesthesiologist the opportunity to view the sur-
gery. A video tape camera can be attached to the 
operating microscope allowing both the scrub nurse 
and the anesthesiologist to view the surgery and also 
the televising of the surgery to any location in the 
hospital, providing greater flexibility of the mi-
croscope as a teaching instrument. 
The important lessons in developing excellent 
microsurgery techniques are learned in the 
microneurosurgical laboratory. An extended period 
of time must be spent in the laboratory learning how 
to handle and drape the microscope as well as to 
learn microneurosurgical instrumentation and 
techniques. The MCV division of Neurosurgery has 
such a laboratory, One should borrow neither the 
ophthalmologists' nor the otolaryngologists' mi-
croscope for an occasional neurosurgical operation 
nor purchase a set of a famous neurosurgeon's in-
struments and expect to immediately perform mag-
nification neurosurgery. 
With the proper use of the microscope, it is 
possible to approach any area in or near the brain to 
safely remove tumors while preserving vital structure. 
For instance, the microscope has been the primary 
reason for the renewed interest in the transsphenoidal 
approach to pituitary surgery. The small secreting 
tumors of the pituitary causing acromegaly can now 
be removed while preserving the pituitary gland (8). 
Summary. Reliable ICP measurement allows an 
exact quantitation and management of intracranial 
pressure. This precise assessment of ICP is a valuable 
adjunct in the management of anesthesia for brain 
tumor patients. The proper combination of ICP and 
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anesthesia management enables the surgeon to use 
the operating microscope to approach previously in-
accessible areas of the brain and to perform 
meticulous surgery with a better prognosis for the 
brain tumor patient. 
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